ライフサイエンスコーパス: antiarrhythmics

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 beta-blocker use, and propensity to receive antiarrhythmics.

2 elopments in the clinical usage of class III antiarrhythmics.

3 3.0 [1.6-5.5]) or used no confounding drugs (antiarrhythmics, 2.4 [1.4-4.3]; QT-prolonging drugs, 3.1

4 Most patients were treated with antiarrhythmics and one third required electrophysiology

5 The impact of various strategies, such as antiarrhythmics and warfarin, aimed at reducing AF and i

6 els are inhibited by many local anesthetics, antiarrhythmics, and antiepileptic drugs.

7 ble of precipitating arrhythmias and include antiarrhythmics, antianginals, antiemetics, gastrointest

8 Antiarrhythmics, anticonvulsants, and local anesthetics

9 rmaceutical interest, including anesthetics, antiarrhythmics, antidepressants, anticonvulsants, antih

10 Amiodarone should be used only when other antiarrhythmics are ineffective or contraindicated.

11 Newer and safer antiarrhythmics are now available.

12 Class III antiarrhythmics are the mainstay of treatment in this gr

13 freedom from AF and 84% freedom from AF off antiarrhythmics at 2 years.

14 ns were rediscovered causing increasing INR (antiarrhythmics class III [amiodarone], other opioids [t

15 Patients comedicated with mibefradil and antiarrhythmics (class I or III), including amiodarone,

16 In patients on antiarrhythmics, dual-site RA prolonged and high RA tren

17 formation regarding amiodarone when choosing antiarrhythmics for acute resuscitation.

18 l problems, yet forward rate dependent (FRD) antiarrhythmics remain elusive.

19 Sodium channel-blocking antiarrhythmics, such as lidocaine, potently inhibit thi

20 Screening for the Antiarrhythmics Versus Implantable Defibrillators (AVID)

21 In the Antiarrhythmics Versus Implantable Defibrillators (AVID)

22 The Antiarrhythmics versus Implantable Defibrillators (AVID)

23 describes the outcomes of patients from the Antiarrhythmics Versus Implantable Defibrillators (AVID)

24 The Antiarrhythmics Versus Implantable Defibrillators (AVID)

25 The Antiarrhythmics Versus Implantable Defibrillators (AVID)

26 ts with VF or symptomatic VT followed in the Antiarrhythmics Versus Implantable Defibrillators (AVID)

27 Data for 491 ICD patients enrolled in the Antiarrhythmics Versus Implantable Defibrillators Study

28 l secondary prevention trials, including the Antiarrhythmics Versus Implantable Defibrillators Study

29 Three-year survival data from the Antiarrhythmics Versus Implantable Defibrillators trail

30 measure generic and disease-specific QoL in Antiarrhythmics Versus Implantable Defibrillators trial

31 Randomized clinical trials such as AVID (Antiarrhythmics Versus Implantable Defibrillators) are d

32 patients using rhythm (class Ia, Ic, and III antiarrhythmics), versus rate control (beta-blockers, ca

33 dom from AF was 93%, and freedom from AF off antiarrhythmics was 82%, at a mean follow-up time of 3.6

34 Epinephrine and antiarrhythmics were administered as per guidelines.

35 er BP medications, aspirin, antibiotics, and antiarrhythmics were associated with survival and consid

36 In addition, novel antiarrhythmics with more atrial specific effects may re

37 A total of 95% of patients were treated with antiarrhythmics, with 43% requiring >1 antiarrhythmic.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。